Acute Myeloid Leukemia Market, Global Outlook and Forecast 2023-2028

Report ID: 1134028 | Published Date: Jan 2025 | No. of Page: 68 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Acute Myeloid Leukemia Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Acute Myeloid Leukemia Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Acute Myeloid Leukemia Overall Market Size
    2.1 Global Acute Myeloid Leukemia Market Size: 2021 VS 2028
    2.2 Global Acute Myeloid Leukemia Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Acute Myeloid Leukemia Players in Global Market
    3.2 Top Global Acute Myeloid Leukemia Companies Ranked by Revenue
    3.3 Global Acute Myeloid Leukemia Revenue by Companies
    3.4 Top 3 and Top 5 Acute Myeloid Leukemia Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Acute Myeloid Leukemia Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia Players in Global Market
        3.6.1 List of Global Tier 1 Acute Myeloid Leukemia Companies
        3.6.2 List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Acute Myeloid Leukemia Market Size Markets, 2021 & 2028
        4.1.2 Chemotherapy
        4.1.3 Targeted Therapy
    4.2 By Type - Global Acute Myeloid Leukemia Revenue & Forecasts
        4.2.1 By Type - Global Acute Myeloid Leukemia Revenue, 2017-2022
        4.2.2 By Type - Global Acute Myeloid Leukemia Revenue, 2023-2028
        4.2.3 By Type - Global Acute Myeloid Leukemia Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Acute Myeloid Leukemia Market Size, 2021 & 2028
        5.1.2 Adults
        5.1.3 Children
    5.2 By Application - Global Acute Myeloid Leukemia Revenue & Forecasts
        5.2.1 By Application - Global Acute Myeloid Leukemia Revenue, 2017-2022
        5.2.2 By Application - Global Acute Myeloid Leukemia Revenue, 2023-2028
        5.2.3 By Application - Global Acute Myeloid Leukemia Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Acute Myeloid Leukemia Market Size, 2021 & 2028
    6.2 By Region - Global Acute Myeloid Leukemia Revenue & Forecasts
        6.2.1 By Region - Global Acute Myeloid Leukemia Revenue, 2017-2022
        6.2.2 By Region - Global Acute Myeloid Leukemia Revenue, 2023-2028
        6.2.3 By Region - Global Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Acute Myeloid Leukemia Revenue, 2017-2028
        6.3.2 US Acute Myeloid Leukemia Market Size, 2017-2028
        6.3.3 Canada Acute Myeloid Leukemia Market Size, 2017-2028
        6.3.4 Mexico Acute Myeloid Leukemia Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Acute Myeloid Leukemia Revenue, 2017-2028
        6.4.2 Germany Acute Myeloid Leukemia Market Size, 2017-2028
        6.4.3 France Acute Myeloid Leukemia Market Size, 2017-2028
        6.4.4 U.K. Acute Myeloid Leukemia Market Size, 2017-2028
        6.4.5 Italy Acute Myeloid Leukemia Market Size, 2017-2028
        6.4.6 Russia Acute Myeloid Leukemia Market Size, 2017-2028
        6.4.7 Nordic Countries Acute Myeloid Leukemia Market Size, 2017-2028
        6.4.8 Benelux Acute Myeloid Leukemia Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Acute Myeloid Leukemia Revenue, 2017-2028
        6.5.2 China Acute Myeloid Leukemia Market Size, 2017-2028
        6.5.3 Japan Acute Myeloid Leukemia Market Size, 2017-2028
        6.5.4 South Korea Acute Myeloid Leukemia Market Size, 2017-2028
        6.5.5 Southeast Asia Acute Myeloid Leukemia Market Size, 2017-2028
        6.5.6 India Acute Myeloid Leukemia Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Acute Myeloid Leukemia Revenue, 2017-2028
        6.6.2 Brazil Acute Myeloid Leukemia Market Size, 2017-2028
        6.6.3 Argentina Acute Myeloid Leukemia Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, 2017-2028
        6.7.2 Turkey Acute Myeloid Leukemia Market Size, 2017-2028
        6.7.3 Israel Acute Myeloid Leukemia Market Size, 2017-2028
        6.7.4 Saudi Arabia Acute Myeloid Leukemia Market Size, 2017-2028
        6.7.5 UAE Acute Myeloid Leukemia Market Size, 2017-2028
7 Players Profiles
    7.1 GSK
        7.1.1 GSK Corporate Summary
        7.1.2 GSK Business Overview
        7.1.3 GSK Acute Myeloid Leukemia Major Product Offerings
        7.1.4 GSK Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.1.5 GSK Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Acute Myeloid Leukemia Major Product Offerings
        7.2.4 Novartis Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Roche
        7.3.1 Roche Corporate Summary
        7.3.2 Roche Business Overview
        7.3.3 Roche Acute Myeloid Leukemia Major Product Offerings
        7.3.4 Roche Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.3.5 Roche Key News
    7.4 Bristol-Myers Squibb
        7.4.1 Bristol-Myers Squibb Corporate Summary
        7.4.2 Bristol-Myers Squibb Business Overview
        7.4.3 Bristol-Myers Squibb Acute Myeloid Leukemia Major Product Offerings
        7.4.4 Bristol-Myers Squibb Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.4.5 Bristol-Myers Squibb Key News
    7.5 Celgene
        7.5.1 Celgene Corporate Summary
        7.5.2 Celgene Business Overview
        7.5.3 Celgene Acute Myeloid Leukemia Major Product Offerings
        7.5.4 Celgene Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.5.5 Celgene Key News
    7.6 Clavis Pharma ASA
        7.6.1 Clavis Pharma ASA Corporate Summary
        7.6.2 Clavis Pharma ASA Business Overview
        7.6.3 Clavis Pharma ASA Acute Myeloid Leukemia Major Product Offerings
        7.6.4 Clavis Pharma ASA Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.6.5 Clavis Pharma ASA Key News
    7.7 Daiichi Sankyo
        7.7.1 Daiichi Sankyo Corporate Summary
        7.7.2 Daiichi Sankyo Business Overview
        7.7.3 Daiichi Sankyo Acute Myeloid Leukemia Major Product Offerings
        7.7.4 Daiichi Sankyo Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.7.5 Daiichi Sankyo Key News
    7.8 Eisai
        7.8.1 Eisai Corporate Summary
        7.8.2 Eisai Business Overview
        7.8.3 Eisai Acute Myeloid Leukemia Major Product Offerings
        7.8.4 Eisai Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.8.5 Eisai Key News
    7.9 Teva
        7.9.1 Teva Corporate Summary
        7.9.2 Teva Business Overview
        7.9.3 Teva Acute Myeloid Leukemia Major Product Offerings
        7.9.4 Teva Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.9.5 Teva Key News
    7.10 Sunesis Pharmaceuticals
        7.10.1 Sunesis Pharmaceuticals Corporate Summary
        7.10.2 Sunesis Pharmaceuticals Business Overview
        7.10.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Major Product Offerings
        7.10.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue in Global Market (2017-2022)
        7.10.5 Sunesis Pharmaceuticals Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Acute Myeloid Leukemia Market Opportunities & Trends in Global Market
    Table 2. Acute Myeloid Leukemia Market Drivers in Global Market
    Table 3. Acute Myeloid Leukemia Market Restraints in Global Market
    Table 4. Key Players of Acute Myeloid Leukemia in Global Market
    Table 5. Top Acute Myeloid Leukemia Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Acute Myeloid Leukemia Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Acute Myeloid Leukemia Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Acute Myeloid Leukemia Product Type
    Table 9. List of Global Tier 1 Acute Myeloid Leukemia Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Acute Myeloid Leukemia Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Acute Myeloid Leukemia Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Acute Myeloid Leukemia Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Acute Myeloid Leukemia Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Acute Myeloid Leukemia Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Acute Myeloid Leukemia Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Acute Myeloid Leukemia Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue, (US$, Mn), 2023-2028
    Table 30. GSK Corporate Summary
    Table 31. GSK Acute Myeloid Leukemia Product Offerings
    Table 32. GSK Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis Acute Myeloid Leukemia Product Offerings
    Table 35. Novartis Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 36. Roche Corporate Summary
    Table 37. Roche Acute Myeloid Leukemia Product Offerings
    Table 38. Roche Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 39. Bristol-Myers Squibb Corporate Summary
    Table 40. Bristol-Myers Squibb Acute Myeloid Leukemia Product Offerings
    Table 41. Bristol-Myers Squibb Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 42. Celgene Corporate Summary
    Table 43. Celgene Acute Myeloid Leukemia Product Offerings
    Table 44. Celgene Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 45. Clavis Pharma ASA Corporate Summary
    Table 46. Clavis Pharma ASA Acute Myeloid Leukemia Product Offerings
    Table 47. Clavis Pharma ASA Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 48. Daiichi Sankyo Corporate Summary
    Table 49. Daiichi Sankyo Acute Myeloid Leukemia Product Offerings
    Table 50. Daiichi Sankyo Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 51. Eisai Corporate Summary
    Table 52. Eisai Acute Myeloid Leukemia Product Offerings
    Table 53. Eisai Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 54. Teva Corporate Summary
    Table 55. Teva Acute Myeloid Leukemia Product Offerings
    Table 56. Teva Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
    Table 57. Sunesis Pharmaceuticals Corporate Summary
    Table 58. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product Offerings
    Table 59. Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Acute Myeloid Leukemia Segment by Type in 2021
    Figure 2. Acute Myeloid Leukemia Segment by Application in 2021
    Figure 3. Global Acute Myeloid Leukemia Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Acute Myeloid Leukemia Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Acute Myeloid Leukemia Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Acute Myeloid Leukemia Revenue in 2021
    Figure 8. By Type - Global Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    Figure 12. US Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    Figure 16. Germany Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 17. France Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    Figure 24. China Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 28. India Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    Figure 30. Brazil Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Acute Myeloid Leukemia Revenue Market Share, 2017-2028
    Figure 33. Turkey Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Acute Myeloid Leukemia Revenue, (US$, Mn), 2017-2028
    Figure 37. GSK Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Roche Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Bristol-Myers Squibb Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Celgene Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Clavis Pharma ASA Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Daiichi Sankyo Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Eisai Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Teva Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sunesis Pharmaceuticals Acute Myeloid Leukemia Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
68
Frequently Asked Questions
Acute Myeloid Leukemia Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Acute Myeloid Leukemia Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Acute Myeloid Leukemia Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports